Induction of p18(INK4c) and its predominant association with CDK4 and CDK6 during myogenic differentiation

Molecular Biology of the Cell

Volumn 7, Issue 10, 1996, Pages 1587-1599

  Franklin, David S ^a,b   Xiong, Yue ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; CARRIER PROTEIN; CDK4 PROTEIN, HUMAN; CDK6 PROTEIN, HUMAN; CDKN2C PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2C; ENZYME INHIBITOR; MUSCLE PROTEIN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; GENE EXPRESSION; MUSCLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; SKELETAL MUSCLE; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; CELL DIVISION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS;

MURINAE;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLE, SKELETAL; ORGAN SPECIFICITY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0029658034     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.7.10.1587     Document Type: Article

References (62)

1. Braun, T., Bober, E., and Arnold, H.H. (1992). Inhibition of muscle differentiation by the adenovirus E1A protein: repression of the transcriptional activating function of the HLH protein Myf-5. Genes Dev. 6, 888-902.
2. Cardoso, M.C., Leonhardt, H., and Nadal-Ginard, B. (1993). Reversal of terminal differentiation and control of DNA replication: cyclin A and cdk2 specifically localize at subnuclear site of DNA replication. Cell 74, 979-992.
3. Caruso, M., Martelli, F., Giordano, A., and Felsani, A. (1993). Regulation of MyoD gene transcription and protein function by the transforming domain of the adenovirus E1A oncoprotein. Oncogene 8, 267-278.
4. ink4. Mol. Cell. Biol. 15, 2682-2688.
5. WAF1/CIP1 mediated by STAT1. Science 272, 719-722.
6. Clegg, C.H., and Hauschka, S.D. (1987). Heterokaryon analysis of muscle differentiation: regulation of the postmitotic state. J. Cell Biol. 105, 937-947.
7. Clegg, C.H., Linkhart, T.A., Olwin, B.B., and Hauschka, S.D. (1987). Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J. Cell Biol. 105, 949-956.
8. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
9. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Lin, D.M, Mercer, W.E., Kinzler, K.W.V, and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
10. Endo, T. (1992). SV40 large T inhibits myogenic differentiation partially through inducing c-jun. J. Biochem. 112, 321-329.
11. Kip1-deficient mice. Cell 85, 733-744.
12. Gu, W., Schneider, J.W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. (1993a). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
13. Gu, Y., Turck, C.W., and Morgan, D.O. (1993b). Inhibition of CDK2 activity in vivo by an associated 20 K regulatory subunit. Nature 366, 707-710.
14. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952.
15. INK4d, a p16-related inhibitor specific to CDK6 and CDK4. Mol. Cell. Biol. 7, 57-70.
16. Guo, K., Wang, J., Andres, V., Smith, R.C., and Walsh, K. (1995). MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15, 3823-3829.
17. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D., and Lassar, A.B. (1995). Terminal cell cycle arrest of skeletal muscle correlates with induction of p21 by MyoD. Science 267, 1018-1021.
18. INK4B is a potential effector of TGF-b-induced cell cycle arrest. Nature 371, 257-261.
19. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
20. Harper, J.W., et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
21. Hirai, H., Roussel, M.F., Kato, J., Ashmun, R.A., and Sherr, C.J. (1995). Novel INK4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681.
22. Hunter, T., and Pines, J. (1994). Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
23. Jahn, L., Sadshima, J.-I., and Izumo, S. (1994). Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp. Cell Res. 212, 297-307.
24. Jenkins, C.W., and Xiong, Y. (1995). Immunoprecipitation and immunoblotting in cell cycle studies. In: Cell Cycle: Material and Methods, ed. M. Pagano, New York: Springer-Verlag, 250-263.
25. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavitgian, S.V., Stockert, E., Day, R.S., Johnson, B.E., and Skolnick, M.H. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440.
26. Kip1. Cell 85, 721-732.
27. Koh, J., Enders, G.H., Dynlacht, B.D., and Harlow, E. (1995). Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510.
28. Kotani, S., Endo, T., Kitagawa, M., Higashi, H., and Onaya, T. (1995). A variant form of cyclin-dependent kinase 2 (CDK2) in a malignantly transformed rat thyroid (FRTL-Tc) cell line. Oncogene 10, 663-669.
29. Lassar, A.B., Skapek, S.X., and Novitch, B. (1994). Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Biol. 6, 788-794.
30. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649.
31. Li, Y., Jenkins, C.W., Nichols, M.A., and Xiong, Y. (1994). Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9, 2261-2268.
32. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-153.
33. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. (1995). Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature 375, 503-506.
34. Kip2, a structurally distinct member of the p21CIP1 CDK inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662.
35. PSK-/3/cdk4) for mammalian D-type G1 cyclins. Cell 71, 323-334.
36. McMahon, D.K., Anderson, P.A.W., Nassar, R., Bunting, J.B., Saba, Z., Oakeley, A.E., and Malouf, N.N. (1994). C2C12 cells: biophysical, biochemical and immunocytological properties. Am. J. Physiol. 266, C1795-C1802.
37. Meyerson, M., Enders, G.H., Wu, C.-L., Su, L.-K., Gorka, C., Neilson, C., Harlow, E., and Tsai, L.-H. (1992). A family of human cdc2-related protein kinases. EMBO J. 11, 2909-2917.
38. Meyerson, M., and Harlow, E. (1994). Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086.
39. Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L.H., Livingston, D.M., and Dotto, G.P. (1995). Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci USA 92, 5451-5455.
40. Mymryk, J.S., Lee, R.W.H., and Bayley, S.T. (1992). Ability of adenovirus 5 E1A protein to suppress differentiation of Bc3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Mol. Biol. Cell 3, 1107-1115.
41. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720.
42. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., and Smith, J.R. (1994). Cloning of senescent cell-derived inhibitor of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98.
43. Okuda, T., Hirai, H., Valentine, V.A., Shurtleff, S.A., Kidd, V.J., Lahti, J.M., Sherr, C.J., and Downing, J.R. (1995). Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases. Genomics 29, 623-630.
44. Olson, E.N., and Klein, W.H. (1994). bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8, 1-8.
45. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Sal, G.D., Chau, V., Yew, P.R., Draetta, G.F., and Rolfe, M. (1995). Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
46. Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027.
47. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
48. INK4b genes. Oncogene 11, 635-645.
49. Schneider, J.W., Gu, W., Zhu, L., Mahdavi, V., and Nadal, G.B. (1994). Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 264, 1467-1471.
50. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
51. Sherr, C.J. (1994). G1 phase progression: cycling on cue. Cell 79, 551-555.
52. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
53. Timchenko, N.A., Wilde, M., Nakanishi, M., Smith, J.R., and Darlington, G.J. (1996). CCAAT/enhancer-binding protein A (C/EBPa) inhibits cell proliferation through the p21 (WAF1/CIP-1/SDI-1) protein. Genes Dev. 10, 804-815.
54. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk proteins kinase activity, is related to p21. Cell 78, 67-74.
55. Weintraub, H. (1993). The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75, 1241-1244.
56. Wright, W.E., Sassoon, D.A., and Lin, V.K. (1989). Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD1. Cell 56, 607-617.
57. Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993a). p21 is a universal inhibitor of the cyclin kinases. Nature 366, 701-704.
58. Xiong, Y., Zhang, H., and Beach, D. (1992). D-Type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71, 505-514.
59. Xiong, Y., Zhang, H., and Beach, D. (1993b). Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7, 1572-1583.
60. Yaffe, D., and Saxel, O. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.
61. Zhang, H., Hannon, G.J., and Beach, D. (1994). p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750-1758.
62. Zhang, H., Xiong, Y., and Beach, D. (1993). Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4, 897-906.